Test Price
2,800 AED✅ Home Collection Available
GGCX Gene Genetic Test in UAE | AED 2800 | DHA Licensed
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% sensitivity via ISO‑accredited NGS platform.
- Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Post‑test telephone consultation for result interpretation.
- Insurance: Direct coverage verification via WhatsApp +971545488731.
Test Overview & Methodology
This advanced NGS analysis identifies pathogenic variants in the GGCX gene underlying combined vitamin K‑dependent coagulation factor deficiency and pseudoxanthoma elasticum‑like skin disorder, empowering precision diagnosis and family‑wide risk assessment.
| Parameter | Our GGCX NGS Test | Closest Alternative (Coagulation Factor Assay) |
|---|---|---|
| Diagnostic Precision | Gold‑standard sequencing; identifies causal mutation | Measures enzyme activity; does not reveal genetic cause |
| Methodology | Next‑Generation Sequencing (NGS) | Chromogenic / clotting assays |
| Turnaround Time | 3 to 4 Weeks | 1–2 Days |
* Genetic confirmation enables lifelong tailored care; factor assays alone cannot differentiate congenital from acquired deficiency.
Physician Insight & Safety Protocols
“As a consultant medical geneticist, I emphasize that identifying a pathogenic variant in the GGCX gene provides a definitive molecular diagnosis for this rare bleeding disorder. It enables precise family counseling and surveillance for pseudoxanthoma elasticum‑like manifestations. However, all genetic results must be interpreted in the context of the full clinical picture, including coagulation factor assays and imaging. Please consult a specialist before initiating any therapy.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Do not discontinue or adjust prescribed anticoagulants or vitamin K supplements without direct consultation with your treating physician. Sudden changes may provoke life‑threatening hemorrhage or thrombosis.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Patients who have received a blood transfusion within the last 2 weeks should defer testing to avoid donor DNA interference. The test cannot be performed on samples with insufficient DNA yield or gross hemolysis.
- Emergency Red Flags: If you experience acute uncontrolled bleeding, severe bruising, sudden severe headache (possible intracranial hemorrhage), or signs of stroke, seek emergency medical attention immediately. This genetic test is not designed for acute bleeding management.
- Minors: For individuals under 18, parental or legal guardian consent is mandatory as per Federal Decree‑Law No. 4 of 2016 on Medical Liability. The request must be accompanied by a valid Emirates ID and a consent form.
Patient FAQ & Clinical Guidance
1. What does the GGCX gene NGS test detect?
This genetic test sequences the entire coding region of the GGCX gene to identify mutations causing combined deficiency of vitamin K‑dependent clotting factors and pseudoxanthoma elasticum‑like disorder, thereby guiding precise clinical management.
2. Who should consider this genetic test?
Individuals with unexplained bleeding tendency, low vitamin K‑dependent factor activity, or skin/eye changes suggestive of pseudoxanthoma elasticum, and their at‑risk relatives, should consider this test for definitive molecular confirmation and family planning.
3. How accurate is the test and what is the turnaround time?
Our ISO‑accredited NGS platform delivers >99.9% diagnostic sensitivity for known variants, with results available in 3 to 4 weeks. The report includes pathogenicity interpretation according to international guidelines, ensuring high clinical utility.
UAE Regulatory & Data Privacy Adherence
UAE Regulatory Compliance: This service fully adheres to Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL), Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, and Federal Decree‑Law No. 4 of 2016 on Medical Liability. Our facility is licensed by the Dubai Health Authority (DHA License No. 1143) and certified to ISO 9001:2015. All data handling follows strict confidentiality protocols.
Clinical & Logistical Metadata
| Test Name | GGCX Gene Genetic Test |
| Price (AED) | AED 2,800 |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Whole Blood (Peripheral) |
| Methodology Used | Next‑Generation Sequencing (NGS) |
| ICD‑10‑CM Code | D68.2 (Congenital deficiency of other clotting factors) |
| LOINC Code | 83753-6 (GGCX gene mutation analysis) |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians